506 related articles for article (PubMed ID: 19505225)
21. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
Mutalik S; Anju P; Manoj K; Usha AN
Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447
[TBL] [Abstract][Full Text] [Related]
22. The novel application of tertiary butyl alcohol in the preparation of hydrophobic drug-HPbetaCD complex.
Wang Z; Deng Y; Zhang X
J Pharm Pharmacol; 2006 Mar; 58(3):409-14. PubMed ID: 16536910
[TBL] [Abstract][Full Text] [Related]
23. Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode.
Yang B; Lin J; Chen Y; Liu Y
Bioorg Med Chem; 2009 Sep; 17(17):6311-7. PubMed ID: 19665897
[TBL] [Abstract][Full Text] [Related]
24. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
Garnero C; Zoppi A; Genovese D; Longhi M
Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
Fathy M; Sheha M
Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
[TBL] [Abstract][Full Text] [Related]
26. Alpinetin/hydroxypropyl-β-cyclodextrin host-guest system: preparation, characterization, inclusion mode, solubilization and stability.
Ma SX; Chen W; Yang XD; Zhang N; Wang SJ; Liu L; Yang LJ
J Pharm Biomed Anal; 2012; 67-68():193-200. PubMed ID: 22633603
[TBL] [Abstract][Full Text] [Related]
27. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
28. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
29. Effects of Kollicoat IR and hydroxypropyl-beta-cyclodextrin on the dissolution rate of omeprazole from its microparticles and enteric-coated capsules.
El-Badry M; Alanazi FK; Mahrous GM; Alsarra IA
Pharm Dev Technol; 2010; 15(5):500-10. PubMed ID: 19814584
[TBL] [Abstract][Full Text] [Related]
30. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
31. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
32. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
[TBL] [Abstract][Full Text] [Related]
33. Inclusion complexation of nimesulide with beta-cyclodextrins.
Vavia PR; Adhage NA
Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
[TBL] [Abstract][Full Text] [Related]
34. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
[TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
Desai C; Prabhakar B
Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
[TBL] [Abstract][Full Text] [Related]
36. Inclusion complex of trimethoprim with beta-cyclodextrin.
Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
[TBL] [Abstract][Full Text] [Related]
37. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
[TBL] [Abstract][Full Text] [Related]
38. Interactions between lonidamine and beta- or hydroxypropyl-beta-cyclodextrin.
Palmieri GF; Wehrlé P; Martelli S
Drug Dev Ind Pharm; 1998 Jul; 24(7):653-60. PubMed ID: 9876510
[TBL] [Abstract][Full Text] [Related]
39. Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.
Zhang X; Wu D; Lai J; Lu Y; Yin Z; Wu W
J Pharm Sci; 2009 Feb; 98(2):665-75. PubMed ID: 18543294
[TBL] [Abstract][Full Text] [Related]
40. Triamterene-beta-cyclodextrin systems: preparation, characterization and in vivo evaluation.
Mukne AP; Nagarsenker MS
AAPS PharmSciTech; 2004 Mar; 5(1):E19. PubMed ID: 15198540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]